GITNUX MARKETDATA REPORT 2024
Semaglutide Elimination Time Statistics
Semaglutide has a mean elimination half-life of approximately 1 week in healthy subjects.
In this post, we explore key statistics related to the elimination time and pharmacokinetics of semaglutide, an important medication for Type 2 Diabetes management. From its low risk of hypoglycemia to its steady-state plasma concentrations and elimination half-life, we delve into various aspects of semaglutide’s efficacy and elimination characteristics based on clinical studies and research findings.
Statistic 1
"Risk of hypoglycemia is low with semaglutide monotherapy."
Statistic 2
"Terminal half-life of semaglutide in patients with Type 2 Diabetes is about 7 days."
Statistic 3
"Semaglutide maintains its efficacy up to 52 weeks in clinical studies."
Statistic 4
"It takes roughly 5-7 weeks for semaglutide to be entirely eliminated from the body."
Statistic 5
"Semaglutide shows similar elimination profiles in both obese and non-obese patients."
Statistic 6
"Semaglutide is primarily eliminated via the liver."
Statistic 7
"Semaglutide has low inter-subject variability in terms of its pharmacokinetics."
Statistic 8
"Steady-state plasma concentrations of semaglutide are achieved with dosing every 4 weeks."
Statistic 9
"Most of the semaglutide dose is excreted through the urine and feces as metabolites."
Statistic 10
"The elimination half-life of semaglutide is approximately one week."
Statistic 11
"After injection, semaglutide has 90% bioavailability."
Statistic 12
"Following subcutaneous administration, peak concentrations of semaglutide are reached in 1 to 3 days."
Statistic 13
"Semaglutide is metabolized to a small extent by the enzyme dipeptidyl peptidase-4 (DPP-4)."
Statistic 14
"It shows a protein binding rate of about 99% in human plasma."
Statistic 15
"Semaglutide significantly reduces HbA1c levels by up to 1.5% over 26 weeks."
Statistic 16
"Semaglutide has a renal clearance rate significantly lower than its total plasma clearance."
Statistic 17
"Semaglutide is well-tolerated with common side effects including nausea and vomiting."
Statistic 18
"Semaglutide's initial dose is often 0.25 mg once weekly, increased as tolerated."
Statistic 19
"Semaglutide's volume of distribution after a subcutaneous dose is around 8 liters."
![Picture of Jannik Lindner](https://gitnux.org/wp-content/uploads/2023/12/jannik_2019-300x300-optimized.jpg)
Jannik Lindner
Can You Trust Our Report?
The statistics are checked by us and then entered into the database. Our market data reports have been linked to by some of the largest publishers and companies on the Internet.